MoonLake Immunotherapeutics News and Activities

MoonLake Immunotherapeutics is a company listed under the stock ticker MLTX (US).

View the org chart displaying its 28 main executives

Most searched biographies at MoonLake Immunotherapeutics

• Jorge Santos Da Silva, Chief Executive Officer
• Andrew Phillips, Director
• Ramnik Xavier, Director

Popular executive movements at MoonLake Immunotherapeutics

• Benjamin Porter-Brown, Chief Medical Officer, has left the company  (posted on February 12 2026).

Create your alert
to follow the executive moves at MoonLake Immunotherapeutics.

MoonLake Immunotherapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by MoonLake Immunotherapeutics

• MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH | MoonLake Immunotherapeutics

Social media about MoonLake Immunotherapeutics

• MoonLake Immunotherapeutics on Wikipedia, Google News & Yahoo Finance
• MoonLake Immunotherapeutics on LinkedIn, X (Twitter) & YouTube